AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn how to implement zero based budgeting in a household setting, aligning multiple incomes and expenses toward goals.
17,999 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
Adobe stock is back in the spotlight as AI reshapes software. This guide explains what drives the buzz, how Adobe ear...
Decision making in investing isn’t just about numbers. It’s shaped by psychology, trends, and how we interpret data. ...
Fomo has closed a $75 million Series B round led by Index Ventures, pushing the company’s valuation to $550 million a...
As July 2 approaches, investors debate whether to buy Tesla stock ahead of the Q2 delivery data. This guide breaks do...
Emails released in SEC filings reveal a heated confrontation between UWM and Two Harbors as the CCM deal vote approac...
Torn between buying Amazon or SpaceX stock? Learn how a broad AI and technology ETF that holds both could simplify yo...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
Cumberland, Fluid, and SwissBorg join Hashi ahead of Sui's July testnet launch, expanding Bitcoin-backed DeFi rails a...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Home Depot is rebuilding retailing with a bold AI-driven strategy, refreshing its technology leadership and rolling o...